Abstract
Introduction In 2014, Mozambique introduced index case testing (ICT) to increase the identification of people living with HIV (PLHIV), including among hard-to-reach populations. The strategy elicits PLHIV’s sexual contacts and biological children for testing at the community and facility levels, improving testing efficiency in detecting HIV among people. We analyzed HIV program data to understand ICT contributions to case identification since 2017.
Methods Routine aggregated program data from the President’s Emergency Plan for AIDS Relief (PEPFAR) Monitoring, Evaluation, and Reporting data were abstracted for 2017–2023. Test positivity was calculated as positive tests over the total number of tests conducted by modality. Data were analyzed by calendar year (January–December), sex, age group (<15, 15– 49, ≥50 years), and ICT setting (community-based, facility-based).
Results During 2017–2023, overall test positivity for all modalities combined decreased from 5.7% (410,430/7,207,532) to 2.9% (297,012/10,190,365), and ICT increased by 92% (from 389,940 tests done in 2017 to 748,265 in 2023). The contribution of ICT to the total number of positive tests increased from 9.0% to 24.5% (37,076/410,430 to 72,622/297,012); among men tested, the contribution of ICT to positive tests increased from 10.2% to 29.9%; among children <15 years tested, from 20.3% to 35.3%; and among 15–49-year-olds tested, from 10.3% to 25.3%. Almost two-thirds (65.3%) of positive tests through ICT were community-based (276,356/ 423,166), with a testing positivity rate of 10.5% (276,356/2,632,862). The overall ICT test positivity rate was 12.0% (423,166/3,535,787) compared to the overall test positivity rate of 4.1% (2,373,985/57,909,176).
Conclusion Over the 7-year period, HIV testing through ICT almost doubled, and one of every four people who tested positive for HIV was detected through ICT. ICT efficiency is demonstrated by a test positivity that is three times higher (12%) than the overall test positivity (4%), with particular efficiencies among hard-to-reach age and sex groups.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This manuscript has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR), through the U.S. Centers for Disease Control and Prevention (CDC), The findings and conclusions in this manuscript are those of the author(s) and do not necessarily represent the official position of the funding agencies.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used PEPFAR Monitoring, Evaluation, and Reporting program.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.